Terms: = Breast cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
105 results:
1. Long noncoding RNA malat1 protects against osteoporosis and bone metastasis.
Zhao Y; Ning J; Teng H; Deng Y; Sheldon M; Shi L; Martinez C; Zhang J; Tian A; Sun Y; Nakagawa S; Yao F; Wang H; Ma L
Nat Commun; 2024 Mar; 15(1):2384. PubMed ID: 38493144
[TBL] [Abstract] [Full Text] [Related]
2. CD95 promotes stemness of colorectal cancer cells by lncRNA malat1.
Gao C; Jia K; Fang J; Zhu X; Hu J; Zhang Y; Jiang J; Yu X; Wang D; Gu H; Chen Z
Life Sci; 2024 Feb; 338():122394. PubMed ID: 38159593
[TBL] [Abstract] [Full Text] [Related]
3. Construction of a Programmable Feedback Network with Continuously Activatable Molecular Beacon Fluorescence for One-Step Quantification of Long Noncoding RNAs in Clinical breast Tissues.
Liu WJ; Zhang L; Zhang CY
Anal Chem; 2023 Nov; 95(44):16343-16351. PubMed ID: 37874866
[TBL] [Abstract] [Full Text] [Related]
4. [JAG1 affects monocytes-macrophages to reshape the pre-metastatic niche of triple-negative breast cancer through LncRNA malat1 in exosomes].
Xu M; Shi Y; Liu J; Wu M; Zhang F; He Z; Tang M
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1525-1535. PubMed ID: 37814867
[TBL] [Abstract] [Full Text] [Related]
5. Construction of ceRNA network and identification of hub differentially expressed genes associated with breast cancer using reanalysis of microarray dataset: A systems biology approach.
Moallemi Rad L; Safarzadeh A; Taheri M; Ghafouri-Fard S; Eghbali A
Pathol Res Pract; 2023 Nov; 251():154838. PubMed ID: 37804544
[TBL] [Abstract] [Full Text] [Related]
6. Targeted Inhibition of lncRNA malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative breast cancer.
Adewunmi O; Shen Y; Zhang XH; Rosen JM
Cancer Immunol Res; 2023 Nov; 11(11):1462-1479. PubMed ID: 37603945
[TBL] [Abstract] [Full Text] [Related]
7. A feedback loop between lncRNA malat1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.
Hu Y; He Y; Luo N; Li X; Guo L; Zhang K
Cancer Biol Ther; 2023 Dec; 24(1):2235768. PubMed ID: 37548553
[TBL] [Abstract] [Full Text] [Related]
8. The malat1-breast cancer interplay: insights and implications.
Tufail M
Expert Rev Mol Diagn; 2023; 23(8):665-678. PubMed ID: 37405385
[TBL] [Abstract] [Full Text] [Related]
9. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative breast cancer by Integrated Bioinformatical Analysis.
Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
[TBL] [Abstract] [Full Text] [Related]
10. Metformin and long non-coding RNAs in breast cancer.
Gholami M; Klashami ZN; Ebrahimi P; Mahboobipour AA; Farid AS; Vahidi A; Zoughi M; Asadi M; Amoli MM
J Transl Med; 2023 Feb; 21(1):155. PubMed ID: 36849958
[TBL] [Abstract] [Full Text] [Related]
11. Mix-and-Detection Assay with Multiple Cyclic Enzymatic Repairing Amplification for Rapid and Ultrasensitive Detection of Long Noncoding RNAs in breast Tissues.
Zhao NN; Yu XD; Tian X; Xu Q; Zhang CY
Anal Chem; 2023 Feb; 95(5):3082-3088. PubMed ID: 36692970
[TBL] [Abstract] [Full Text] [Related]
12. HIF-1α/malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative breast cancer.
Xu F; Hu Y; Gao J; Wang J; Xie Y; Sun F; Wang L; Miyamoto A; Xia O; Zhang C
Curr Cancer Drug Targets; 2023; 23(5):363-378. PubMed ID: 36579395
[TBL] [Abstract] [Full Text] [Related]
13. Potential serum metabolites and long-chain noncoding RNA biomarkers for endometrial cancer tissue.
Hao C; Lin S; Liu P; Liang W; Li Z; Li Y
J Obstet Gynaecol Res; 2023 Feb; 49(2):725-743. PubMed ID: 36510632
[TBL] [Abstract] [Full Text] [Related]
14. lncRNA
Shi C; Ren S; Zhao X; Li Q
Pharmacogenomics; 2022 Dec; 23(18):973-985. PubMed ID: 36420706
[No Abstract] [Full Text] [Related]
15. Baicalin suppresses the migration and invasion of breast cancer cells via the TGF-β/lncRNA-malat1/miR-200c signaling pathway.
Li J; Liu H; Lin Q; Chen H; Liu L; Liao H; Cheng Y; Zhang X; Wang Z; Shen A; Chen G
Medicine (Baltimore); 2022 Nov; 101(46):e29328. PubMed ID: 36401368
[TBL] [Abstract] [Full Text] [Related]
16. Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women.
El-Helkan B; Emam M; Mohanad M; Fathy S; Zekri AR; Ahmed OS
Sci Rep; 2022 Nov; 12(1):19498. PubMed ID: 36376369
[TBL] [Abstract] [Full Text] [Related]
17. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer.
Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J
J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884
[TBL] [Abstract] [Full Text] [Related]
18. Functional roles of long noncoding RNA malat1 in gynecologic cancers.
Farzaneh M; Najafi S; Dari MAG; Sheykhi-Sabzehpoush M; Dayer D; Cheraghzadeh M; Azizidoost S
Clin Transl Oncol; 2023 Jan; 25(1):48-65. PubMed ID: 36042115
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model.
Motalebzadeh J; Eskandari E
Breast Cancer; 2022 Nov; 29(6):1050-1066. PubMed ID: 35871431
[TBL] [Abstract] [Full Text] [Related]
20. malat1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer.
Turco C; Esposito G; Iaiza A; Goeman F; Benedetti A; Gallo E; Daralioti T; Perracchio L; Sacconi A; Pasanisi P; Muti P; Pulito C; Strano S; Ianniello Z; Fatica A; Forcato M; Fazi F; Blandino G; Fontemaggi G
Commun Biol; 2022 Jun; 5(1):598. PubMed ID: 35710947
[TBL] [Abstract] [Full Text] [Related]
[Next]
